Probiotics and blood pressure: Current insights

Integrated Blood Pressure Control

Volumn 9, Issue , 2016, Pages 33-42

  Upadrasta, Aditya ^a   Madempudi, Ratna Sudha ^a  

^a Unique Biotech Limited   (India)

Author keywords

ACE; Gut microbiota; Hypertension; Metabolic disorders; Metagenomics; Probiotics

Indexed keywords

ASCORBIC ACID; BILE ACID; DIPEPTIDYL CARBOXYPEPTIDASE; MINERAL; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; TRIMETHYLAMINE OXIDE; VITAMIN D; YOGHURT;

BACTEROIDES; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CALCIUM ABSORPTION; CARDIOVASCULAR DISEASE; DYSBIOSIS; EATING HABIT; FERMENTED PRODUCT; FUNCTIONAL FOOD; HUMAN; HYPERTENSION; INTESTINE FLORA; LACTIC ACID BACTERIUM; METABOLIC DISORDER; MICROBIAL COLONIZATION; NONHUMAN; PREHYPERTENSION; PREVOTELLA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VITAMIN D DEFICIENCY;

EID: 84959325364     PISSN: None     EISSN: 11787104     Source Type: Journal    
DOI: 10.2147/IBPC.S73246     Document Type: Review

References (102)

1. Sanders ME, Guarner F, Guerrant R, et al. An update on the use and investigation of probiotics in health and disease. Gut. 2013;62(5):787-796.
2. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(2 Suppl):444S-450S.
3. Klaenhammer TR, Kleerebezem M, Kopp MV, Rescigno M. The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol. 2012;12(10):728-734.
4. Food and Agriculture Organization of the United Nations/World Health Organization. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO/WHO; 2001. Available from: ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf. Accessed December 19, 2015.
5. Alakomi HL, Skytta E, Saarela M, Mattila-Sandholm T, Latva-Kala K, Helander IM. Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl Environ Microbiol. 2000;66(5):2001-2005.
6. Atassi F, Servin AL. Individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain Lactobacillus johnsonii ncc933 and vaginal strain Lactobacillus gasseri ks120.1 against enteric, uropathogenic and vaginosis-associated pathogens. FEMS Microbiol Lett. 2010;304(1):29-38.
7. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CG. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A. 2007;104(18):7617-7621.
8. Dobson A, Cotter PD, Ross RP, Hill C. Bacteriocin production: A probiotic trait? Appl Environ Microbiol. 2012;78(1):1-6.
9. Naidu AS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (lab). Crit Rev Food Sci Nutr. 1999;39(1):13-126.
10. Stanton C, Ross RP, Fitzgerald GF, Sinderen DV. Fermented functional foods based on probiotics and their biogenic metabolites. Curr Opin Biotechnol. 2005;16(12):198-203.
11. Vandenbergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiology Reviews. 1993;12(1-3):221-237.
12. Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012;113(2):411-417.
13. Upadrasta A, Stanton C, Hill C, Fitzgerald G, Ross RP. Improving the stress tolerance of probiotic cultures: Recent trends and future directions. In: Tsakalidou E, Papadimitriou K, editors. Stress responses of lactic acid bacteria. Springer US; 2011:395-438.
14. Sudha RM, Bhonagiri S. Efficacy of Bacillus coagulans strain unique is-2 in the treatment of patients with acute diarrhea. International Journal of Probiotics and Prebiotics. 2012;7(1):33-37.
15. Ettinger G, MacDonald K, Reid G, Burton JP. The influence of the human microbiome and probiotics on cardiovascular health. Gut Microbes. 2014;5(6):719-728.
16. Fariborz A, Aziz H. Dairy probiotic foods and coronary heart disease: A review on mechanism of action. Intech; 2012.
17. Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension. 2014;64(4):897-903.
18. Liong MT. Probiotics: a critical review of their potential role as antihypertensives, immune modulators, hypocholesterolemics, and perimenopausal treatments. Nutr Rev. 2007;65(7):316-328.
19. Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT. The improvement of hypertension by probiotics: Effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci. 2009;10(9):3755-3775.
20. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-223.
21. Hayakawa K, Kimura M, Kasaha K, Matsumoto K, Sansawa H, Yamori Y. Effect of a gamma-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive wistar-kyoto rats. Br J Nutr. 2004;92(3):411-417.
22. Inoue K, Shirai T, Ochiai H, et al. Blood-pressure-lowering effect of a novel fermented milk containing [gamma]-aminobutyric acid (gaba) in mild hypertensives. Eur J Clin Nutr. 2003;57(3):490-495.
23. Hennessy AA, Ross RP, Devery R, Stanton C. The health promoting properties of the conjugated isomers of alpha linolenic acid. Lipids. 2011;46(2):105-119.
24. Hernández-Ledesma B, Amigo L, Ramos M, Recio I. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. J Agric Food Chem. 2004;52(6):1504-1510.
25. Okamoto A, Hanagata H, Matsumoto E, Kawamura Y, Koizumi Y, Yanagida F. Angiotensin I converting enzyme inhibitory activities of various fermented foods. Biosci Biotechnol Biochem. 1995;59(6):1147-1149.
26. Seppo L, Kerojoki O, Suomalainen T, Korpela R. The effect of a Lactobacillus helveticus lbk-16 h fermented milk on hypertension: A pilot study on humans. Milchwissenschaft. 2002;57(3):124-127.
27. Stanton C, Gardiner G, Meehan H, et al. Market potential for probiotics. Am J Clin Nutr. 2001;73(2 Suppl):476S-483S.
28. Ross RP, Fitzgerald G, Collins K, Stanton C. Cheese delivering biocultures--probiotic cheese. Australian Journal of Dairy Technology. 2002;57:71-78.
29. Xiao JZ, Kondo S, Takahashi N, et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci. 2003;86(7):2452-2461.
30. Itsaranuwat P, Al-Haddad KS, Robinson RK. The potential therapeutic benefits of consuming 'health-promoting' fermented dairy products: a brief update. International Journal of Dairy Technology. 2003;56(4):203-210.
31. Gawkowski D, Chikindas ML. Non-dairy probiotic beverages: the next step into human health. Benef Microbes. 2013;4(2):127-142.
32. Gill SR, Pop M, DeBoy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355-1359.
33. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635-1638.
34. Bocci V. The neglected organ: bacterial flora has a crucial immunostimulatory role. Perspect Biol Med. 1992;35(2):251-260.
35. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7(7):688-693.
36. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJM, Relman DA. The application of ecological theory toward an understanding of the human microbiome. Science. 2012;336(6086):1255-1262.
37. Walter J, Ley R. The human gut microbiome: Ecology and recent evolutionary changes. Annu Rev Microbiol. 2011;65:411-429.
38. Bäckhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17(5):690-703.
39. Dogra S, Sakwinska O, Soh SE, et al. Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity. MBio. 2015;6(1). pii: e02419-e02414.
40. Kalliomäki M, Carmen Collado M, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr. 2008;87(3):534-538.
41. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med. 2014;6:(237):237ra65.
42. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-1131.
43. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS One. 2010;5(2):e9085.
44. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55-60.
45. Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil. 2011;23(3):187-192.
46. Foster JA, Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-312.
47. Mulle JG, Sharp WG, Cubells JF. The gut microbiome: a new frontier in autism research. Curr Psychiatry Rep. 2013;15(2):337.
48. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 2011;121(6):2126-2132.
49. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science. 2010;328(5975):228-231.
50. Bennett BJ, de Aguiar Vallim TQ, Wang Z, et al. Trimethylamine-n-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17(1):49-60.
51. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57-63.
52. Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH, Chen Y. Carnitine metabolism to trimethylamine by an unusual rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A. 2014;111(11):4268-4273.
53. Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension a scientific statement from the American heart association. Hypertension. 2006;47(2):296-308.
54. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336(16):1117-1124.
55. Bernstein AM, Sun Q, Hu FB, Stampfer MJ, Manson JE, Willett WC. Major dietary protein sources and risk of coronary heart disease in women. Circulation. 2010;122(9):876-883.
56. Jenkins DJ, Kendall CW, Marchie A, et al. The Garden of Eden-plant based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century. Comp Biochem Physiol A Mol Integr Physiol. 2003;136(1):141-151.
57. Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus a systematic review and meta-analysis. Circulation. 2010;121(21):2271-2283.
58. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576-585.
59. Miura K, Greenland P, Stamler J, Liu K, Daviglus ML, Nakagawa H. Relation of vegetable, fruit, and meat intake to 7-year blood pressure change in middle-aged men the Chicago western electric study. Am J Epidemiol. 2004;159(6):572-580.
60. Shanahan F, McCarthy J. Functional foods and probiotics: time for gastroenterologists to embrace the concept. Curr Gastroenterol Rep. 2000;2(5):345-346.
61. Peters J. Molecular basis of human hypertension: the role of angiotensin. Baillières Clin Endocrinol Metab. 1995;9(3):657-678.
62. Marc Y, Llorens-Cortes C. The role of the brain renin-angiotensin system in hypertension: implications for new treatment. Prog Neurobiol. 2011;95(2):89-103.
63. FitzGerald RJ, Murray BA, Walsh DJ. Hypotensive peptides from milk proteins. J Nutr. 2004;134(4):980S-988S.
64. Morgan L, Pipkin FB, Kalsheker N. Angiotensinogen: molecular biology, biochemistry and physiology. Int J Biochem Cell Biol. 1996;28(11):1211-1222.
65. Ebel B, Lemetais G, Beney L, et al. Impact of probiotics on risk factors for cardiovascular diseases. A review. Crit Rev Food Sci Nutr. 2014;54(2):175-189.
66. Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin-angiotensin system. Circulation. 1993;87(6):1816-1828.
67. Pluznick J. A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes. 2014;5(2):202-207.
68. Liu M, Bayjanov JR, Renckens B, Nauta A, Siezen RJ. The proteolytic system of lactic acid bacteria revisited: a genomic comparison. BMC Genomics. 2010;11:36.
69. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268-1273.
70. Gordon JI. Honor thy gut symbionts redux. Science. 2012;336(6086):1251-1253.
71. Korhonen H. Milk-derived bioactive peptides: From science to applications. Journal of Functional Foods. 2009;1(2):177-187.
72. FitzGerald RJ, Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr. 2000;84 Suppl 1:S33-37.
73. London LEE, Kumar AHS, Wall R, et al. Exopolysaccharide-producing probiotic lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice. J Nutr. 2015;144(12):1956-1962.
74. Marques TM, Wall R, O'Sullivan O, et al. Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. Br J Nutr. 2015;113(5):728-738.
75. Lyte M, Cryan JF, Wall R, et al. Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol. 2014;817:221-239.
76. Pluznick JL, Protzko RJ, Gevorgyan H, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A. 2013;110(11):4410-4415.
77. Yang T, Santisteban MM, Rodriguez V, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331-1340.
78. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol. 2009;6(10):621-630.
79. Kienreich K, Tomaschitz A, Verheyen N, et al. Vitamin D and cardiovascular disease. Nutrients. 2013;5(8):3005-3021.
80. Jones ML, Martoni CJ, Prakash S. Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial. J Clin Endocrinol Metab. 2013;98(7):2944-2951.
81. Santos F, Wegkamp A, de Vos WM, Smid EJ, Hugenholtz J. High-level folate production in fermented foods by the B12 producer Lactobacillus reuteri JCM1112. Appl Environ Microbiol. 2008;74(10):3291-3294.
82. Taranto MP, Vera JL, Hugenholtz J, De Valdez GF, Sesma F. Lactobacillus reuteri CRL1098 produces cobalamin. J Bacteriol. 2003;185(18):5643-5647.
83. Santos F, Vera JL, van der Heijden R, et al. The complete coenzyme b12 biosynthesis gene cluster of Lactobacillus reuteri CRL1098. Microbiology. 2008;154(Pt 1):81-93.
84. Ness AR, Chee D, Elliott P. Vitamin C and blood pressure--an overview. J Hum Hypertens. 1997;11(6):343-350.
85. Juraschek SP, Guallar E, Appel LJ, Miller ER 3rd. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;95(5):1079-1088.
86. Kim MK, Sasaki S, Sasazuki S, Okubo S, Hayashi M, Tsugane S. Lack of long-term effect of vitamin c supplementation on blood pressure. Hypertension. 2002;40(6):797-803.
87. Houston MC. Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals. Expert Rev Cardiovasc Ther. 2007;5(4):681-691.
88. Ghanem KZ, Badawy IH, Abdel-Salam AM. Influence of yoghurt and probiotic yoghurt on the absorption of calcium, magnesium, iron and bone mineralization in rats. Milchwissenschaft. 2004;59(9):472-475.
89. Sheridan PO, Bindels LB, Saulnier DM, et al. Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals? Gut Microbes. 2014;5(1):74-82.
90. Mizushima S, Ohshige K, Watanabe J, et al. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens. 2004;17(8):701-706.
91. Nakajima K, Hata Y, Osono Y, Hamura M, Kobayashi S, Watanuki M. Antihypertensive effect of extracts of Lactobacillus casei in patients with hypertension. Journal of Clinical Biochemistry and Nutrition. 1995;18(3):181-187.
92. Al-Okbi SY, Mohamad D, Hamed T, Afifi AA, Mohamad SH. Reduction of the risk of cardiovascular diseases through dietary mixtures and probiotic. The Medical Journal of Cairo University. 2010;78(2).
93. Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H, Nurminen M-L. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol. 2001;52:745-754
94. Dong JY, Szeto IM, Makinen K, et al. Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr. 2013;110(7):1188-1194.
95. Tanida M, Yamano T, Maeda K, Okumura N, Fukushima Y, Nagai K. Effects of intraduodenal injection of Lactobacillus johnsonii la1 on renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats. Neurosci Lett. 2005;389(2):109-114.
96. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr. 2002;76(6):1249-1255.
97. Donkor ON, Henriksson A, Singh TK, Vasiljevic T, Shah NP. Ace-inhibitory activity of probiotic yoghurt. International Dairy Journal. 2007;17(11):1321-1331.
98. Hayes M, Stanton C, Slattery H, et al. Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors. Appl Environ Microbiol. 2007;73(14):4658-4667.
99. Tsai JS, Lin YS, Pan BS, Chen TJ. Antihypertensive peptides and γ-aminobutyric acid from prozyme 6 facilitated lactic acid bacteria fermentation of soymilk. Process Biochemistry. 2006;41(6):1282-1288.
100. Tripolt NJ, Leber B, Triebl A, Köfeler H, Stadlbauer V, Sourij H. Effect of Lactobacillus casei Shirota supplementation on trimethylamine-n-oxide levels in patients with metabolic syndrome: An open-label, randomized study. Atherosclerosis. 2015;242(1):141-144.
101. Kawase M, Hashimoto H, Hosoda M, Morita H, Hosono A. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J Dairy Sci. 2000;83(2):255-263.
102. Sharafedtinov KK, Plotnikova OA, Alexeeva RI, et al. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients-a randomized double-blind placebo-controlled pilot study. Nutr J. 2013;12:138.